An Integrated Risk Reduction Intervention can reduce body mass index in individuals being treated for bipolar I disorder: Results from a randomized trial

Bipolar Disorders

Volumn 17, Issue 4, 2015, Pages 424-437

  Frank, Ellen ^a   Wallace, Meredith L ^a   Hall, Martica ^a   Hasler, Brant ^a   Levenson, Jessica C ^a   Janney, Carol A ^a   Soreca, Isabella ^a   Fleming, Matthew C ^a   Buttenfield, Joan ^a   Ritchey, Fiona C ^a   Kupfer, David J ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Bipolar disorder; Health risks; Weight management

Indexed keywords

ARIPIPRAZOLE; C REACTIVE PROTEIN; CHOLESTEROL; LITHIUM SALT; QUETIAPINE; VALPROATE SEMISODIUM;

ADULT; ARTICLE; BIPOLAR I DISORDER; BODY MASS; CARDIOMETABOLIC RISK; CHOLESTEROL BLOOD LEVEL; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; FEMALE; HUMAN; INTEGRATED RISK REDUCTION INTERVENTION; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MOOD; NURSE; OBESITY; OUTPATIENT CARE; PATIENT MONITORING; PATIENT REFERRAL; PRIORITY JOURNAL; PSYCHIATRIC TREATMENT; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; SLEEP TIME; SOCIAL PSYCHOLOGY; AFFECT; BIPOLAR DISORDER; CHEMICALLY INDUCED; DRUG EFFECTS; INTEGRATED HEALTH CARE SYSTEM; MIDDLE AGED; OVERWEIGHT; PSYCHOLOGY; REFERENCE VALUE; SOCIAL ADAPTATION;

ADULT; AFFECT; BIPOLAR DISORDER; BODY MASS INDEX; DELIVERY OF HEALTH CARE, INTEGRATED; FEMALE; HUMANS; LIFE STYLE; MALE; MIDDLE AGED; OBESITY; OVERWEIGHT; REFERENCE VALUES; RISK REDUCTION BEHAVIOR; SOCIAL ADJUSTMENT;

EID: 84930416441     PISSN: 13985647     EISSN: 13995618     Source Type: Journal    
DOI: 10.1111/bdi.12283     Document Type: Article

References (47)

1. Kessler RC, Akiskal HS, Ames M et al. Prevalence and effects of mood disorders on work performance in a nationally representative sample of U.S. workers. Am J Psychiatry 2006; 163: 1561-1568.
2. Revicki DA, Matza LS, Flood E, Lloyd A. Bipolar disorder and health-related quality of life: review of burden of disease and clinical trials. Pharmacoeconomics 2005; 23: 583-594.
3. Fagiolini A, Forgione R, Maccari M et al. Prevalence, chronicity, burden and borders of bipolar disorder. J Affect Disord 2013; 148: 161-169.
4. Dilsaver SC. An estimate of the minimum economic burden of bipolar I and II disorders in the United States: 2009. J Affect Disord 2011; 129: 79-83.
5. Kupfer DJ. The increasing medical burden in bipolar disorder. JAMA 2005; 293: 2528-2530.
6. Perron BE, Howard MO, Nienhuis JK, Bauer MS, Woodward AT, Kilbourne AM. Prevalence and burden of general medical conditions among adults with bipolar I disorder: results from the national epidemiologic survey on alcohol and related conditions. J Clin Psychiatry 2009; 70: 1407-1415.
7. Grande I, Kunz M, Potter W, Balanza-Martinez V, Vieta E, Kapczinski F. Should bipolar disorder be considered a systemic illness? Neuropsychiatry 2011; 1: 45-54.
8. Roshanaei-Moghaddam B, Katon W. Premature mortality from general medical illnesses among persons with bipolar disorder: a review. Psychiatr Serv 2009; 60: 147-156.
9. Black DW, Winokur G, Hulbert J, Nasrallah A. Predictors of immediate response in the treatment of mania: the importance of comorbidity. Biol Psychiatry 1988; 24: 191-198.
10. Black DW, Winokur G, Nasrallah A. Effect of psychosis on suicide risk in 1, 593 patients with unipolar and bipolar affective disorders. Am J Psychiatry 1988; 145: 849-852.
11. Black DW, Winokur G, Mohandoss E, Woolson RF, Nasrallah A. Does treatment influence mortality in depressives? A follow-up of 1076 patients with major affective disorders. Ann Clin Psychiatry 1989; 1: 165-173.
12. Fagiolini A, Kupfer DJ, Houck PR, Novick DM, Frank E. Obesity as a correlate of outcome in patients with bipolar I disorder. Am J Psychiatry 2003; 160: 112-117.
13. Fagiolini A, Frank E, Scott JA, Turkin S, Kupfer DJ. Metabolic syndrome in bipolar disorder: findings from the Bipolar Disorder Center for Pennsylvanians. Bipolar Disord 2005; 7: 424-430.
14. Swartz HA, Fagiolini A. Cardiovascular disease and bipolar disorder: risk and clinical implications. J Clin Psychiatry 2012; 73: 1563-1565.
15. Hajek T, Slaney C, Garnham J, Ruzickova M, Passmore M, Alda M. Clinical correlates of current level of functioning in primary care-treated bipolar patients. Bipolar Disord 2005; 7: 286-291.
16. Crump C, Sundquist K, Winkleby MA, Sundquist J. Comorbidities and mortality in bipolar disorder: a Swedish national cohort study. JAMA Psychiatry 2013; 70: 931-939.
17. Judd LL, Akiskal HS, Schetteler PJ et al. The long-term natural history of the weekly symptomatic status of bipolar I disorder. Arch Gen Psychiatry 2002; 59: 530-537.
18. Judd LL, Akiskal HS, Schettler PJ et al. A prospective investigation of the natural history of the long-term weekly symptomatic status of bipolar II disorder. Arch Gen Psychiatry 2003; 60: 261-269.
19. Judd LL, Akiskal HS, Schettler PJ et al. Psychosocial disability in the course of bipolar I and II disorders. Arch Gen Psychiatry 2005; 62: 1322-1330.
20. Katon WJ. Clinical and health services relationships between major depression, depressive symptoms, and general medical illness. Biol Psychiatry 2003; 54: 216-226.
21. Fagiolini A, Frank E, Houck PR et al. Prevalence of obesity and weight change during treatment in patients with bipolar I disorder. J Clin Psychiatry 2002; 63: 528-533.
22. Fagiolini A, Kupfer DJ, Scott J et al. Hypothyroidism in patients with bipolar I disorder treated primarily with lithium. Epidemiol Psichiatr Soc 2006; 15: 123-127.
23. Fagiolini A, Frank E, Soreca I, Houck PR, Kupfer DJ. Integrating medical and psychiatric care in patients with bipolar disorder. J Clin Psychopharmacol 2008; 28: 257-258.
24. Soreca I, Fagiolini A, Frank E, Houck PR, Thompson WK, Kupfer DJ. Relationship of general medical burden, duration of illness and age in patients with bipolar I disorder. J Psychiatr Res 2008; 42: 956-961.
25. Soreca I, Frank E, Kupfer DJ. The phenomenology of bipolar disorder: what drives the high rate of medical burden and determines long-term prognosis? Depress Anxiety 2009; 26: 73-82.
26. Soreca I, Fagiolini A, Frank E, Goodpaster BH, Kupfer DJ. Chronotype and body composition in bipolar disorder. Chronobiol Int 2009; 26: 780-788.
27. Knutson KL, Van Cauter E. Associations Between Sleep Loss and Increased Risk of Obesity and Diabetes. Malden, MA: Blackwell Publishing, 2008: 287-304.
28. Rosenwasser AM. Circadian clock genes: non-circadian roles in sleep, addiction, and psychiatric disorders? Neurosci Biobehav Rev 2010; 34: 1249-1255.
29. Mezick EJ, Hall M, Matthews KA. Are sleep and depression independent or overlapping risk factors for cardiometabolic disease? Sleep Med Rev 2011; 15: 51-63.
30. Soreca I, Wallace ML, Frank E, Hasler BP, Levenson JC, Kupfer DJ. Sleep duration is associated with dyslipidemia in patients with bipolar disorder in clinical remission. J Affect Disord 2012; 141: 484-487.
31. Depner CM, Stothard ER, Wright KP Jr. Metabolic consequences of sleep and circadian disorders. Curr Diab Rep 2014; 14: 507.
32. Sachs GS, Thase ME, Otto MW et al. Rationale, design, and methods of the systematic treatment enhancement program for bipolar disorder. Biol Psychiatry 2003; 53: 1028-1042.
33. Kraemer HC. Discovering, comparing, and combining moderators of treatment on outcome after randomized clinical trials: a parametric approach. Stat Med 2013; 32: 1964-1973.
34. Wallace ML, Frank E, Kraemer HC. A novel approach for developing and interpreting treatment moderator profiles in randomized clinical trials. JAMA Psychiatry 2013; 70: 1241-1247.
35. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23: 56-61.
36. Young RC, Biggs JT, Ziegler VE, Meyer DA. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 1978; 133: 429-435.
37. Spearing MK, Post RM, Leverich GS, Brandt D, Nolen W. Modification of the clinical global impressions (CGI) scale for use in bipolar illness (BP): the CGI-BP. Psychiatry Res 1997; 73: 159-171.
38. Frank E, Kupfer DJ, Thase ME et al. Two-year outcomes for interpersonal and social rhythm therapy in individuals with bipolar I disorder. Arch Gen Psychiatry 2005; 62: 996-1004.
39. Miklowitz DJ, Otto MW, Frank E et al. Psychosocial treatments for bipolar depression: a 1-year randomized trial from the systematic treatment enhancement program. Arch Gen Psychiatry 2007; 64: 419-427.
40. Jahng S, Wood PK, Trull TJ. Analysis of affective instability in ecological momentary assessment: indices using successive difference and group comparison via multilevel modeling. Psychol Methods 2008; 13: 354-375.
41. Janney CA, Bauer MS, Kilbourne AM. Self-management and bipolar disorder-a clinician's guide to the literature 2011-2014. Curr Psychiatry Rep 2014; 16: 485.
42. Frank E. Treating Bipolar Disorder: A Clinician's Guide to Interpersonal and Social Rhythm Therapy. New York, NY: Guilford Press, 2005.
43. Kretschmer E. Physique and Character. Oxford: Harcourt Brace, 1925.
44. Fiedorowicz JG, Palagummi NM, Forman-Hoffman V, Miller DD, Haynes WG. Elevated prevalence of obesity, metabolic syndrome, and cardiovascular risk factors in bipolar disorder. Ann Clin Psychiatry 2008; 20: 131-137.
45. Fiedorowicz JG, Solomon DA, Endicott J et al. Manic/hypomanic symptom burden and cardiovascular mortality in bipolar disorder. Psychosom Med 2009; 71: 598-606.
46. Hickie IB, Scott EM, Hermens DF et al. Applying clinical staging to young people who present for mental health care. Early Interv Psychiatry 2013; 7: 31-43.
47. McEwen BS, Stellar E. Stress and the individual: mechanisms leading to disease. Arch Intern Med 1993; 153: 2093-2101.